VEGFA and vitreous hemorrhage: Postoperatively, best-corrected visual acuity (BCVA) improved from preoperative hand motion to counting fingers at one month, but subsequently declined due to recurrent vitreous hemorrhage despite initial improvement and subsequent anti-vascular endothelial growth factor (anti-VEGF) therapy refusal.